Pacer Advisors Inc. raised its stake in shares of Leidos Holdings, Inc. (NYSE:LDOS – Free Report) by 94.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 19,834 shares of the aerospace company’s stock after acquiring an additional 9,654 shares during the quarter. Pacer Advisors Inc.’s holdings in Leidos were worth $2,857,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also made changes to their positions in LDOS. FMR LLC boosted its position in Leidos by 27.8% during the third quarter. FMR LLC now owns 2,405,726 shares of the aerospace company’s stock valued at $392,133,000 after purchasing an additional 522,764 shares in the last quarter. JPMorgan Chase & Co. lifted its position in shares of Leidos by 13.1% during the third quarter. JPMorgan Chase & Co. now owns 3,504,392 shares of the aerospace company’s stock valued at $571,216,000 after buying an additional 405,256 shares during the last quarter. International Assets Investment Management LLC grew its position in shares of Leidos by 24,194.3% in the 3rd quarter. International Assets Investment Management LLC now owns 377,047 shares of the aerospace company’s stock worth $61,459,000 after buying an additional 375,495 shares during the last quarter. Allspring Global Investments Holdings LLC raised its stake in shares of Leidos by 51.2% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 837,370 shares of the aerospace company’s stock worth $136,491,000 after acquiring an additional 283,558 shares in the last quarter. Finally, Barclays PLC lifted its position in Leidos by 53.1% during the third quarter. Barclays PLC now owns 576,022 shares of the aerospace company’s stock valued at $93,891,000 after acquiring an additional 199,686 shares during the last quarter. 76.12% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at Leidos
In other Leidos news, Director Noel B. Geer bought 2,000 shares of Leidos stock in a transaction dated Wednesday, November 20th. The stock was acquired at an average cost of $161.13 per share, with a total value of $322,260.00. Following the purchase, the director now directly owns 2,000 shares in the company, valued at $322,260. This represents a ∞ increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Surya N. Mohapatra sold 2,748 shares of the business’s stock in a transaction on Thursday, November 7th. The stock was sold at an average price of $194.97, for a total transaction of $535,777.56. Following the completion of the sale, the director now directly owns 20,001 shares of the company’s stock, valued at approximately $3,899,594.97. The trade was a 12.08 % decrease in their position. The disclosure for this sale can be found here. 0.96% of the stock is owned by corporate insiders.
Leidos Stock Down 0.0 %
Leidos (NYSE:LDOS – Get Free Report) last posted its earnings results on Tuesday, October 29th. The aerospace company reported $2.93 earnings per share for the quarter, beating the consensus estimate of $1.96 by $0.97. Leidos had a net margin of 7.37% and a return on equity of 30.31%. The firm had revenue of $4.19 billion during the quarter, compared to analyst estimates of $4.06 billion. During the same period in the previous year, the firm earned $2.03 EPS. The business’s quarterly revenue was up 6.9% on a year-over-year basis. As a group, sell-side analysts anticipate that Leidos Holdings, Inc. will post 10.03 earnings per share for the current year.
Analysts Set New Price Targets
LDOS has been the topic of a number of recent analyst reports. TD Cowen downgraded Leidos from a “buy” rating to a “hold” rating and reduced their price target for the stock from $200.00 to $165.00 in a research report on Wednesday, January 8th. UBS Group started coverage on Leidos in a report on Monday, December 2nd. They issued a “neutral” rating and a $182.00 price target for the company. Royal Bank of Canada upped their price objective on shares of Leidos from $145.00 to $180.00 and gave the company a “sector perform” rating in a report on Wednesday, October 30th. Robert W. Baird lifted their target price on shares of Leidos from $180.00 to $218.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 30th. Finally, Barclays upped their price target on shares of Leidos from $165.00 to $210.00 and gave the company an “overweight” rating in a research note on Monday, November 4th. Five research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $179.07.
Read Our Latest Research Report on Leidos
About Leidos
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
See Also
- Five stocks we like better than Leidos
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Nebius Group: Market Overreaction or Real AI Disruption?
- What is Forex and How Does it Work?
- The Best Way to Invest in Gold Is…
- Profitably Trade Stocks at 52-Week Highs
- Why Nike Stock Could Be 2025’s Top Comeback Play
Want to see what other hedge funds are holding LDOS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Leidos Holdings, Inc. (NYSE:LDOS – Free Report).
Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.